CLINICAL_TRIALS
trial_result
· 2015-07-16
Clinical Trial Update: Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus [Phase 1]
Summary
A Phase 1 safety study of CDP7657 in patients with systemic lupus erythematosus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Immune System Diseases, Autoimmune Diseases | Phase 1 | Status: COMPLETED